Cargando…

The impact of intravenous iron supplementation in elderly patients undergoing major surgery

BACKGROUND: Age and preoperative anaemia are risk factors for poor surgical outcome and blood transfusion. The aim of this study was to examine the effect of iron supplementation in iron-deficient (ID) elderly patients undergoing major surgery. METHOD: In this single-centre observational study, pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Blum, Lea Valeska, Zierentz, Philipp, Hof, Lotta, Kloka, Jan Andreas, Messroghli, Leila, Zacharowski, Kai, Meybohm, Patrick, Choorapoikayil, Suma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988356/
https://www.ncbi.nlm.nih.gov/pubmed/35392839
http://dx.doi.org/10.1186/s12877-022-02983-y
_version_ 1784682943261704192
author Blum, Lea Valeska
Zierentz, Philipp
Hof, Lotta
Kloka, Jan Andreas
Messroghli, Leila
Zacharowski, Kai
Meybohm, Patrick
Choorapoikayil, Suma
author_facet Blum, Lea Valeska
Zierentz, Philipp
Hof, Lotta
Kloka, Jan Andreas
Messroghli, Leila
Zacharowski, Kai
Meybohm, Patrick
Choorapoikayil, Suma
author_sort Blum, Lea Valeska
collection PubMed
description BACKGROUND: Age and preoperative anaemia are risk factors for poor surgical outcome and blood transfusion. The aim of this study was to examine the effect of iron supplementation in iron-deficient (ID) elderly patients undergoing major surgery. METHOD: In this single-centre observational study, patients ≥ 65 years undergoing major surgery were screened for anaemia and ID. Patients were assigned to the following groups: A(−) (no anaemia); A(−),ID(+),T(+) (no anaemia, iron-deficient, intravenous iron supplementation); A(+) (anaemia); and A(+),ID(+),T(+) (anaemia, iron-deficient, intravenous iron supplementation). RESULTS: Of 4,381 patients screened at the anaemia walk-in clinic, 2,381 (54%) patients were ≥ 65 years old and 2,191 cases were included in analysis. The ID prevalence was 63% in patients with haemoglobin (Hb) < 8 g/dl, 47.2% in patients with Hb from 8.0 to 8.9 g/dl, and 44.3% in patients with Hb from 9 to 9.9 g/dl. In severely anaemic patients, an Hb increase of 0.6 (0.4; 1.2) and 1.2 (0.7; 1.6) g/dl was detected with iron supplementation 6–10 and > 10 days before surgery, respectively. Hb increased by 0 (-0.1; 0) g/dl with iron supplementation 1–5 days before surgery, 0.2 (-0.1; 0.5) g/dl with iron supplementation 6–10 days before surgery, and 0.2 (-0.2; 1.1) g/dl with supplementation > 10 days before surgery (p < 0.001 for 1–5 vs. 6–10 days). Overall, 58% of A(+),ID(+),T(+) patients showed an Hb increase of > 0.5 g/dl. The number of transfused red blood cell units was significantly lower in patients supplemented with iron (0 (0; 3)) compared to non-treated anaemic patients (1 (0; 4)) (p = 0.03). Patients with iron supplementation > 6 days before surgery achieved mobility 2 days earlier than patients with iron supplementation < 6 days. CONCLUSIONS: Intravenous iron supplementation increases Hb level and thereby reduces blood transfusion rate in elderly surgical patients with ID anaemia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-02983-y.
format Online
Article
Text
id pubmed-8988356
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89883562022-04-08 The impact of intravenous iron supplementation in elderly patients undergoing major surgery Blum, Lea Valeska Zierentz, Philipp Hof, Lotta Kloka, Jan Andreas Messroghli, Leila Zacharowski, Kai Meybohm, Patrick Choorapoikayil, Suma BMC Geriatr Research BACKGROUND: Age and preoperative anaemia are risk factors for poor surgical outcome and blood transfusion. The aim of this study was to examine the effect of iron supplementation in iron-deficient (ID) elderly patients undergoing major surgery. METHOD: In this single-centre observational study, patients ≥ 65 years undergoing major surgery were screened for anaemia and ID. Patients were assigned to the following groups: A(−) (no anaemia); A(−),ID(+),T(+) (no anaemia, iron-deficient, intravenous iron supplementation); A(+) (anaemia); and A(+),ID(+),T(+) (anaemia, iron-deficient, intravenous iron supplementation). RESULTS: Of 4,381 patients screened at the anaemia walk-in clinic, 2,381 (54%) patients were ≥ 65 years old and 2,191 cases were included in analysis. The ID prevalence was 63% in patients with haemoglobin (Hb) < 8 g/dl, 47.2% in patients with Hb from 8.0 to 8.9 g/dl, and 44.3% in patients with Hb from 9 to 9.9 g/dl. In severely anaemic patients, an Hb increase of 0.6 (0.4; 1.2) and 1.2 (0.7; 1.6) g/dl was detected with iron supplementation 6–10 and > 10 days before surgery, respectively. Hb increased by 0 (-0.1; 0) g/dl with iron supplementation 1–5 days before surgery, 0.2 (-0.1; 0.5) g/dl with iron supplementation 6–10 days before surgery, and 0.2 (-0.2; 1.1) g/dl with supplementation > 10 days before surgery (p < 0.001 for 1–5 vs. 6–10 days). Overall, 58% of A(+),ID(+),T(+) patients showed an Hb increase of > 0.5 g/dl. The number of transfused red blood cell units was significantly lower in patients supplemented with iron (0 (0; 3)) compared to non-treated anaemic patients (1 (0; 4)) (p = 0.03). Patients with iron supplementation > 6 days before surgery achieved mobility 2 days earlier than patients with iron supplementation < 6 days. CONCLUSIONS: Intravenous iron supplementation increases Hb level and thereby reduces blood transfusion rate in elderly surgical patients with ID anaemia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12877-022-02983-y. BioMed Central 2022-04-07 /pmc/articles/PMC8988356/ /pubmed/35392839 http://dx.doi.org/10.1186/s12877-022-02983-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Blum, Lea Valeska
Zierentz, Philipp
Hof, Lotta
Kloka, Jan Andreas
Messroghli, Leila
Zacharowski, Kai
Meybohm, Patrick
Choorapoikayil, Suma
The impact of intravenous iron supplementation in elderly patients undergoing major surgery
title The impact of intravenous iron supplementation in elderly patients undergoing major surgery
title_full The impact of intravenous iron supplementation in elderly patients undergoing major surgery
title_fullStr The impact of intravenous iron supplementation in elderly patients undergoing major surgery
title_full_unstemmed The impact of intravenous iron supplementation in elderly patients undergoing major surgery
title_short The impact of intravenous iron supplementation in elderly patients undergoing major surgery
title_sort impact of intravenous iron supplementation in elderly patients undergoing major surgery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988356/
https://www.ncbi.nlm.nih.gov/pubmed/35392839
http://dx.doi.org/10.1186/s12877-022-02983-y
work_keys_str_mv AT blumleavaleska theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT zierentzphilipp theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT hoflotta theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT klokajanandreas theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT messroghlileila theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT zacharowskikai theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT meybohmpatrick theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT choorapoikayilsuma theimpactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT blumleavaleska impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT zierentzphilipp impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT hoflotta impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT klokajanandreas impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT messroghlileila impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT zacharowskikai impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT meybohmpatrick impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery
AT choorapoikayilsuma impactofintravenousironsupplementationinelderlypatientsundergoingmajorsurgery